The following information appeared on, CMS.gov
CMS is increasing the Medicare payment rate for administering monoclonal anti-bodies to treat patients with COVID-19.
Effective May 6, the national payment rate will be $450 for most healthcare settings, up from the previous rate of $310. CMS also said its national payment rate will increase to $750 when monoclonal anti-bodies are administered in the patient’s home.
“These higher national average payment rates reflect additional information provided to CMS about the costs of providing these services in a safe and timely manner, such as clinical staff and personal protective equipment. This action also means Medi-care payments to providers and suppliers will be more aligned to their costs to admin-ister these products,” CMS said.
